𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Cytolytic activity against tumor cells by macrophage cell lines and augmentation by macrophage stimulants

✍ Scribed by Tadayoshi Taniyama; Howard T. Holden


Publisher
John Wiley and Sons
Year
1980
Tongue
French
Weight
806 KB
Volume
26
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Previous studies have shown that macrophage cell lines retained the ability to phagocytize, to secrete lysosomal enzymes, and to function as effector cells in antibody‐dependent cellular cytotoxicity. In this paper, the cytolytic activity of murine macrophage cell lines against tumor target cells was assessed using an 18‐h ^51^Cr release assay. Of the macrophage cell lines tested, RAW 264, PU5‐1.8 and IC‐21 had intermediate to high levels of spontaneous cytolytic activity, P388D~1~ and J774 had low to intermediate levels, while WEHI‐3 showed little or no cytolytic activity against RBL‐5, MBL‐2 and TU‐5 target cells. Tumor‐cell killing by macrophage cell lines could be augmented by the addition of macrophage stimulants, such as bacterial lipopolysaccharide and poly I:C, indicating that the activation of macrophages by these stimulants does not require the participation of other cell types. Treatment with interferon also augmented the tumor‐cell killing by macrophage cell lines. Although the mechanism by which these cell lines exert their spontaneous or boosted cytotoxic activity is not clear, it does not appear to be due to depletion of nutrients since cell lines with high metabolic and proliferative activities, such as WEHI‐3 and RBL‐5, showed little or no cytotoxicity and supernatants from the macrophage cell lines did not exert any cytotoxic effects in their assay. Thus, it appears that the different macrophage cell lines represent different levels of activation and/or differentiation and may be useful for studying the development of these processes as well as providing a useful tool for analyzing the mechanisms of macrophage‐mediated cytolysis.


📜 SIMILAR VOLUMES


Variation in selectivity of tumor cell c
✍ Robert H. Wiltrout; Michael J. Brunda; Howard T. Holden 📂 Article 📅 1982 🏛 John Wiley and Sons 🌐 French ⚖ 847 KB

## Abstract Several murine tumor‐cell lines were tested by isotope release assays for their susceptibility to lysis by either activated peritoneal macrophages (apMPh), macrophage‐like (MPh‐like) cell lines, or natural killer (NK) cells. The qualitative selectivity of tumor‐cell lysis by these diffe

Selective inhibition by monosaccharides
✍ Michael J. Brunda; Robert H. Wiltrout; Howard T. Holden; Luigi Varesio 📂 Article 📅 1983 🏛 John Wiley and Sons 🌐 French ⚖ 834 KB

## Abstract A series of monosaccharides were tested for their ability to inhibit the effector phase of macrophage‐mediated cytolysis against two susceptible murine tumor target cells, L5I78Y and RL♂I. Two monosaccharides, D‐mannose and __N__‐acetyl‐D‐galactosamine, were found to decrease cytotoxici

Properties of colony-stimulating factors
✍ Kazunori Ohki; Ariaki Nagayama 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 946 KB

Colony-stimulating factors (CSFs) produced by two simian virus 40(SV40) transformed macrophage cell lines ( BAMl and BAM3 ), and three hybrids derived from fusion between BAM3 and a Chinese hamster cell line (hs222-16) were examined. HM3-11 and HM3-14 produce two molecular species of CSF, which are

Schizophyllan (SPG)-treated macrophages
✍ Isamu Sugawara; Kwok Choy Lee; Mabel Wong 📂 Article 📅 1984 🏛 Springer-Verlag 🌐 English ⚖ 850 KB

We tested anti-tumor activities of macrophages treated with a neutral polysaccharide, schizophyllan (SPG), against syngeneic and allogeneic tumor cell lines. SPG was a macrophage stimulant which was not mitogenic to lymphocytes. That made a sharp contrast with the data that Corynebacterium parvum, B